Related Experiment Video
Updated: Jan 20, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Cripto-1 overexpression in U87 glioblastoma cells activates MAPK, focal adhesion and ErbB pathways
Faisal Alowaidi1, Saeed M Hashimi2, Naif Alqurashi2
1Department of Pathology and Laboratory Medicine, College of Medicine and University Hospital, King Saud University, Riyadh 11461, Saudi Arabia.
Abstract:
Discovering the underlying signalling pathways that control cancer cells is crucial for understanding their biology and to develop therapeutic regimens. Thus, the aim of the present study was to determine the effect of Cripto-1 on pathways controlling glioblastoma (GBM) cell function. To this end, changes in protein phosphorylation in cells overexpressing Cripto-1 were analysed using the Kyoto Encyclopedia of Genes and Genomes pathway analysis tool, as well as the Uniprot resource to identify the functions of Cripto-1-dependent phosphorylated proteins. This revealed that proteins affected by Cripto-1 overexpression are involved in multiple signalling pathways. The mitogen-activated protein kinase (MAPK), focal adhesion (FA) and ErbB pathways were found to be enriched by Cripto-1 overexpression with 35, 27 and 24% of pathway proteins phosphorylated, respectively. These pathways control important cellular processes in cancer cells that correlate with the observed functional changes described in earlier studies. More specifically, Cripto-1 may regulate MAPK cellular proliferation and survival pathways by activating epithelial growth factor receptor (EGFR; Ser1070) or fibroblast GFR1 (Tyr654). Its effect on cellular proliferation and survival could be mediated through Src (Tyr418), FA kinase (FAK; Tyr396), p130CAS (Tyr410), c-Jun (Ser63), Paxillin (PXN; Tyr118) and BCL2 (Thr69) of the FA pathway. Cripto-1 may also control cellular motility and invasion by activating Src (Tyr418), FAK (Tyr396) and PXN (Tyr118) of the FA pathway. However, Cripto-1 regulation of cellular invasion and migration might be not limited to the FA pathway, it may also control these cellular mechanisms through signalling via EGFR (Ser1070)/Her2 (Tyr877) to mediate the Src (Tyr418) and FAK (Tyr396) cascade activation of the ErbB signalling pathway. Angiogenesis could be mediated by Cripto-1 by activating c-Jun (Ser63) through EGFR (Ser1070)/Her2 (Tyr877) of the ErbB pathway. To conclude, the present study has augmented and enriched our current knowledge on the crucial roles that Cripto-1 may play in controlling different cellular mechanisms in GBM cells.
Insights
Cripto-1 overexpression significantly impacts glioblastoma (GBM) cell function by activating key signaling pathways like MAPK, focal adhesion, and ErbB. This research illuminates Cripto-1
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Understanding cancer cell signaling pathways is critical for developing effective cancer therapies.
- Glioblastoma (GBM) is an aggressive brain tumor with complex underlying molecular mechanisms.
- Cripto-1 is a protein implicated in various cellular processes, including cancer development.
Purpose of the Study:
- To investigate the specific effects of Cripto-1 on signaling pathways that regulate glioblastoma (GBM) cell function.
- To identify the key phosphorylated proteins and pathways influenced by Cripto-1 overexpression in GBM cells.
Main Methods:
- Overexpression of Cripto-1 in glioblastoma cells.
- Analysis of protein phosphorylation changes using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
- Identification of protein functions using the Uniprot resource.
Main Results:
- Cripto-1 overexpression significantly impacts multiple signaling pathways, including MAPK (35% proteins phosphorylated), focal adhesion (FA) (27%), and ErbB (24%).
- Cripto-1 regulates GBM cell proliferation and survival via pathways involving EGFR, FGFR1, Src, FAK, p130CAS, c-Jun, Paxillin, and BCL2.
- Cripto-1 influences cellular motility and invasion through the FA and ErbB pathways, potentially involving EGFR, Her2, Src, and FAK.
Conclusions:
- Cripto-1 plays a crucial role in controlling diverse cellular mechanisms within glioblastoma cells.
- The identified signaling pathways (MAPK, FA, ErbB) provide potential therapeutic targets for GBM treatment.
- Further research into Cripto-1's regulatory functions can enhance our understanding of GBM biology and treatment strategies.
More Related Videos
09:23Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
11:22Quantitative In vitro Assay to Measure Neutrophil Adhesion to Activated Primary Human Microvascular Endothelial Cells under Static Conditions
Published on: August 23, 2013
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Cell Adhesion in Plants
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...